KOE · 353810.KQ
EASY BIO,Inc.
₩5,260-₩90 (-1.68%)
EASY BIO,Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.55% below the high.
Loading market information…
KOE · 083790.KQ · KRW
Stock price, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
CG Invites Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CG Invites Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CG Invites Co., Ltd., based in Seoul, South Korea, specializes in the groundbreaking discovery and progression of novel medical treatments. Founded on July 7, 2000, by Cho Joong Myung and Ro Seong Gu, the company's operations are divided into two main areas. Its Pharmaceutical Research and Development segment primarily focuses on utilizing digital genomics for drug innovation. Additionally, the Automation Equipment division is responsible for manufacturing machinery, including hot pack and printed circuit board (PCB) equipment.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩5,260-₩90 (-1.68%)
EASY BIO,Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.55% below the high.
₩10,900-₩50 (-0.46%)
Macrogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.85% below the high.
₩3,050+₩80 (+2.69%)
MedPacto, Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.74% below the high.
₩2,790-₩85 (-2.96%)
iNtRON Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.2% below the high.
₩916+₩10 (+1.1%)
Amicogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.77% below the high.
₩4,675-₩185 (-3.81%)
Encell Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 77.68% below the high.
₩2,670-₩215 (-7.45%)
GeneOne Life Science, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.56% below the high.
₩2,875-₩155 (-5.12%)
Oncocross Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.16% below the high.
